BRANO
The 14th Branislav “Brano”
Radovancevic International
Heart Failure Forum
Innovations and
New Treatment Strategies
in Heart Failure
September 6th – 8 th, 2022
Savoia Excelsior Palace
Trieste / Italy
BRANO
The 14th Branislav “Brano”
Radovancevic International
Heart Failure Forum
Innovations and
New Treatment Strategies
in Heart Failure
September 6th – 8 th, 2022
Savoia Excelsior Palace
Trieste / Italy
- Greeteings
Ugolino Livi, University Hospital, Udine, Italy
Close
- Start-Up of a Perfusion Education Program
Eric Solberg, Houston, USA
Close
- ECMO in Primary Graft Dysfunction – How Long?
Ruzica Mrkonjic, Zagreb, CRO
Close
- GDP (Goal-Directed Perfusion) strategy in ECC:
Advantages and Opportunities
Marco Ranucci, Milan, IT
Close
- ECMO in COVID 19: Neurological Outcomes
Lisa Janowiak, Houston, USA
Close
- Advances in HF Treatments: Education for Staff
Marie Clark, Houston, USA
Close
- Organizing Mechanical Circulatory Support:
Personnel Requirements
Saso Klesnik, Houston, USA
Close
- ECMO in Primary Graft Dysfunction – How Long?
Ruzica Mrkonjic, Zagreb, CRO
Close
- Reducing gaseous microemboli
Kulic Slavko
Close
- ECMO in COVID 19: Neurological Outcomes
Lisa Janowiak, Houston, USA
Close
- First Line LV venting option: IABP or IMPELLA
or Apical Drainage
Cristiano Amarelli, Napoli, IT
Close
- Technical Issues in Transmedics Organ Preservation
Andrea Lechiancole, Udine, IT
Close
- The Role of Purification in Organ Transplantation
Massimo Boffini, Turin, IT
Close
- Pulsatile ECMO: a new Generation of Cardiac Assistance
Paolo Meani, Milan, IT
Close
- End-stage Heart Failure: 50 years of Promises
and Accomplishments
O.H. Frazier, Houston, USA
Close
- Effect of SARS-Cov-2 on Cardiovascular System
Marco Merlo, Trieste, IT
Close
- Update on Heart Failure Pharmacology Therapies
Paul Mohacsi, Bern, SWI
Close
- Allocation of Hospital Resources in COVID-19 Pandemic
Bindu Akkanti, Houston, USA
Close
- Update on Cardiac Resynchronisation Therapy
A. Kosztin
Close
- Temporary MCS: “Escalation and De-Escalation Strategies
Aly El-Banayosy, Oklahoma City, USA
Close
- ECMO and HEMOLUNG in COVID 19
Kha Dinh, Houston, USA
Close
- ECMELLA 2.0
Angelo Nascimbene, Houston, USA
Close
- Cardiogenic Shock and Temporary Circulatory Support
Bart Meyns, Leuven, BEL
Close
- Surgical Technique of Ecmella 2.0 and 2.1
Evgenij Potapov, Berlin, GER
Close
- Five-Year Momentum Outcome Data with the HeartMate3
Nir Uriel, New York, USA
Close
- Perioperative Management and Neurological Complications
after LVAD Implant
James Long, Oklahoma City, USA
Close
- How to Avoid LVAD Patients Visiting an Emergency Department?
Martin Strueber, Memphis, USA
Close
- 3D Planing for LVADs: Chest Fitting, LIS Surgical Approach,
Outflow Graft Positioning
Istvan Hartyanszky, Budapest, HUN
Close
- Impact of Worsening Aortic Regurgitation on Outcomes
in 396 LVAD Recipients
Hrvoje Gasparovic, Zagreb, CRO
Close
- Pulsatile Versus Non-pulsatile Blood Flow
Walter Dembitsky, San Diego, USA
Close
- CH-VAD
Frank Lin, Torrance, USA
Close
- FineHeart
Francis Pagani, Ann Arbor, USA
Close
- TORVAD
Richard W. Smalling, Houston, USA
Close
- Total Heart Replacement
O.H. Frazier, Houston, USA
Close